Prime Medicine Files for IPO

Prime Medicine Files for IPO

By Stephen Nakrosis Biotech company Prime Medicine Inc. filed an initial public offering with the U.S. Securities and Exchange Commission on Friday. The company said it is “committed to delivering a new class of unique curative gene therapies differentiated to address the broadest spectrum of diseases by deploying our Prime Editing technology.” Earlier this month, …

Prime Medicine Files for IPO Read More »